Enliven Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for Enliven Therapeutics stock have an average target of 38.2, with a low estimate of 34 and a high estimate of 42. The average target predicts an increase of 124.05% from the current stock price of 17.05.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$34	$38.2	$39	$42
Change	+99.41%	+124.05%	+128.74%	+146.33%

Analyst Ratings

The average analyst rating for Enliven Therapeutics stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	3	4	4	4	4	4
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	5	5	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $37 → $39	Strong Buy	Maintains	$37 → $39	+128.74%	Mar 21, 2025
Justin Zelin BTIG	BTIG	Strong Buy Initiates $42	Strong Buy	Initiates	$42	+146.33%	Dec 13, 2024
Colleen Kusy Baird	Baird	Buy Maintains $32 → $40	Buy	Maintains	$32 → $40	+134.60%	Nov 15, 2024
Soumit Roy Jones Trading	Jones Trading	Strong Buy Initiates $36	Strong Buy	Initiates	$36	+111.14%	Oct 31, 2024
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $37	Strong Buy	Reiterates	$37	+117.01%	Oct 1, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 72.89M

Revenue Next Year

n/a

EPS This Year

-2.27

from -1.89

EPS Next Year

-2.66

from -2.27

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029
Revenue	10.20K	10.20K	12.75K	2.56M	72.89M
Revenue Growth	-	-	25.00%	20,001.96%	2,744.05%	-	-	-
EPS	-3.80	-3.17	-12.05	-2.01	-1.89	-2.27	-2.66	-3.17
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	11	9	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	52,500	52,500	52,500
Avg	10,200	10,200	12,750
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-99.9%	414.7%	414.7%
Avg	-100.0%	-	25.0%
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-1.98	-1.86	-1.79
Avg	-2.27	-2.66	-3.17
Low	-2.49	-3.83	-4.30

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.